1-3 of 3
Klaus Herfarth
Close
Sort by
Journal Articles

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

Annette M. Staiger, Eva Hoster, Vindi Jurinovic, Stefan Winter, Ellen Leich, Claudia Kalla, Peter Möller, Heinz-Wolfram Bernd, Alfred C. Feller, Karoline Koch, Wolfram Klapper, Harald Stein, Martin-Leo Hansmann, Sylvia Hartmann, Martin Dreyling, Oliver Weigert, Wolfgang Hiddemann, Klaus Herfarth, Andreas Rosenwald, Marianne Engelhard, German Ott, Heike Horn
Journal: Blood
Blood (2020) 135 (3): 181–190.
https://doi.org/10.1182/blood.2019000560
Published: 2020
Includes: Supplemental data
Journal Articles

Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))

Klaus Herfarth, MD, Marianne Engelhard, MD, Peter Borchmann, MD, Karin Hohloch, MD, Volker Budach, MD, Andreas Viardot, MD, Mathias Witzens-Harig, MD, Hans Eich, MD, Wolfgang Hiddemann, MD, PhD, Martin Dreyling
Journal: Blood
Blood (2012) 120 (21): 1634.
https://doi.org/10.1182/blood.V120.21.1634.1634
Published: 2012
Journal Articles

Clinical Outcome of Patients with Follicular Lymphoma and Bulky Disease After Rituximab-CHOP Immunochemotherapy with and without Consolidating Radiotherapy.

Fabienne McClanahan, MD, Thomas Hielscher, Michael Rieger, MD, Manfred Hensel, MD, PhD, Kai Neben, Jens Hillengass, MD, Klaus Herfarth, MD, PhD, Anthony D. Ho, MD, PhD, Mathias Witzens-Harig, MD
Journal: Blood
Blood (2009) 114 (22): 2722.
https://doi.org/10.1182/blood.V114.22.2722.2722
Published: 2009